OBJECTIVES: The aim of this study was to define the genetic basis of arrhythmogenic right ventricular cardiomyopathy (ARVC). BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy, characterized by right ventricular fibrofatty replacement and arrhythmias, causes sudden death. Autosomal dominant inheritance, reduced penetrance, and 7 desmosome-encoding causative genes are known. The basis of low penetrance is poorly understood. METHODS: Arrhythmogenic right ventricular cardiomyopathy probands and family members were enrolled, blood was obtained, lymphoblastoid cell lines were immortalized, deoxyribonucleic acid was extracted, polymerase chain reaction (PCR) amplification of desmosome-encoding genes was performed, PCR products were sequenced, and diseased tissue samples were studied for intercellular junction protein distribution with confocal immunofluorescence microscopy and antibodies against key proteins. RESULTS: We identified 21 variants in plakophilin-2 (PKP2) in 38 of 198 probands (19%), including missense, nonsense, splice site, and deletion/insertion mutations. Pedigrees showed wide intra-familial variability (severe early-onset disease to asymptomatic individuals). In 9 of 38 probands, PKP2 variants were identified that were encoded in trans (compound heterozygosity). The 38 probands hosting PKP2 variants were screened for other desmosomal genes mutations; second variants (digenic heterozygosity) were identified in 16 of 38 subjects with PKP2 variants (42%), including desmoplakin (DSP) (n = 6), desmoglein-2 (DSG2) (n = 5), plakophilin-4 (PKP4) (n = 1), and desmocollin-2 (DSC2) (n = 1). Heterozygous mutations in non-PKP 2 desmosomal genes occurred in 14 of 198 subjects (7%), including DSP (n = 4), DSG2 (n = 5), DSC2 (n = 3), and junctional plakoglobin (JUP) (n = 2). All variants occurred in conserved regions; none was identified in 700 ethnic-matched control subjects. Immunohistochemical analysis demonstrated abnormalities of protein architecture. CONCLUSIONS: These data suggest that the genetic basis of ARVC includes reduced penetrance with compound and digenic heterozygosity. Disturbed junctional cytoarchitecture in subjects with desmosomal mutations confirms that ARVC is a disease of the desmosome and cell junction. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
OBJECTIVES: The aim of this study was to define the genetic basis of arrhythmogenic right ventricular cardiomyopathy (ARVC). BACKGROUND:Arrhythmogenic right ventricular cardiomyopathy, characterized by right ventricular fibrofatty replacement and arrhythmias, causes sudden death. Autosomal dominant inheritance, reduced penetrance, and 7 desmosome-encoding causative genes are known. The basis of low penetrance is poorly understood. METHODS:Arrhythmogenic right ventricular cardiomyopathy probands and family members were enrolled, blood was obtained, lymphoblastoid cell lines were immortalized, deoxyribonucleic acid was extracted, polymerase chain reaction (PCR) amplification of desmosome-encoding genes was performed, PCR products were sequenced, and diseased tissue samples were studied for intercellular junction protein distribution with confocal immunofluorescence microscopy and antibodies against key proteins. RESULTS: We identified 21 variants in plakophilin-2 (PKP2) in 38 of 198 probands (19%), including missense, nonsense, splice site, and deletion/insertion mutations. Pedigrees showed wide intra-familial variability (severe early-onset disease to asymptomatic individuals). In 9 of 38 probands, PKP2 variants were identified that were encoded in trans (compound heterozygosity). The 38 probands hosting PKP2 variants were screened for other desmosomal genes mutations; second variants (digenic heterozygosity) were identified in 16 of 38 subjects with PKP2 variants (42%), including desmoplakin (DSP) (n = 6), desmoglein-2 (DSG2) (n = 5), plakophilin-4 (PKP4) (n = 1), and desmocollin-2 (DSC2) (n = 1). Heterozygous mutations in non-PKP 2 desmosomal genes occurred in 14 of 198 subjects (7%), including DSP (n = 4), DSG2 (n = 5), DSC2 (n = 3), and junctional plakoglobin (JUP) (n = 2). All variants occurred in conserved regions; none was identified in 700 ethnic-matched control subjects. Immunohistochemical analysis demonstrated abnormalities of protein architecture. CONCLUSIONS: These data suggest that the genetic basis of ARVC includes reduced penetrance with compound and digenic heterozygosity. Disturbed junctional cytoarchitecture in subjects with desmosomal mutations confirms that ARVC is a disease of the desmosome and cell junction. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Authors: Darshan Dalal; Cynthia James; Rajiv Devanagondi; Crystal Tichnell; April Tucker; Kalpana Prakasa; Philip J Spevak; David A Bluemke; Theodore Abraham; Stuart D Russell; Hugh Calkins; Daniel P Judge Journal: J Am Coll Cardiol Date: 2006-09-12 Impact factor: 24.094
Authors: Zhao Yang; Neil E Bowles; Steven E Scherer; Michael D Taylor; Debra L Kearney; Shuping Ge; Vyacheslav V Nadvoretskiy; Gilberto DeFreitas; Blasé Carabello; Lois I Brandon; Lisa M Godsel; Kathleen J Green; Jeffrey E Saffitz; Hua Li; Gian Antonio Danieli; Hugh Calkins; Frank Marcus; Jeffrey A Towbin Journal: Circ Res Date: 2006-08-17 Impact factor: 17.367
Authors: J Peter van Tintelen; Mark M Entius; Zahurul A Bhuiyan; Roselie Jongbloed; Ans C P Wiesfeld; Arthur A M Wilde; Jasper van der Smagt; Ludolf G Boven; Marcel M A M Mannens; Irene M van Langen; Robert M W Hofstra; Luuk C Otterspoor; Pieter A F M Doevendans; Luz-Maria Rodriguez; Isabelle C van Gelder; Richard N W Hauer Journal: Circulation Date: 2006-03-27 Impact factor: 29.690
Authors: Darshan Dalal; Lorraine H Molin; Jonathan Piccini; Crystal Tichnell; Cynthia James; Chandra Bomma; Kalpana Prakasa; Jeffrey A Towbin; Frank I Marcus; Philip J Spevak; David A Bluemke; Theodore Abraham; Stuart D Russell; Hugh Calkins; Daniel P Judge Journal: Circulation Date: 2006-03-20 Impact factor: 29.690
Authors: Nancy D Merner; Kathy A Hodgkinson; Annika F M Haywood; Sean Connors; Vanessa M French; Jörg-Detlef Drenckhahn; Christine Kupprion; Kalina Ramadanova; Ludwig Thierfelder; William McKenna; Barry Gallagher; Lynn Morris-Larkin; Anne S Bassett; Patrick S Parfrey; Terry-Lynn Young Journal: Am J Hum Genet Date: 2008-02-28 Impact factor: 11.025
Authors: Jamie D Kapplinger; Andrew P Landstrom; Benjamin A Salisbury; Thomas E Callis; Guido D Pollevick; David J Tester; Moniek G P J Cox; Zahir Bhuiyan; Hennie Bikker; Ans C P Wiesfeld; Richard N W Hauer; J Peter van Tintelen; Jan D H Jongbloed; Hugh Calkins; Daniel P Judge; Arthur A M Wilde; Michael J Ackerman Journal: J Am Coll Cardiol Date: 2011-06-07 Impact factor: 24.094
Authors: Francesca Brun; Carl V Barnes; Gianfranco Sinagra; Dobromir Slavov; Giulia Barbati; Xiao Zhu; Sharon L Graw; Anita Spezzacatene; Bruno Pinamonti; Marco Merlo; Ernesto E Salcedo; William H Sauer; Matthew R G Taylor; Luisa Mestroni Journal: J Med Genet Date: 2014-08-25 Impact factor: 6.318
Authors: Wouter P Te Rijdt; Jan Dh Jongbloed; Rudolf A de Boer; Gaetano Thiene; Cristina Basso; Maarten P van den Berg; J Peter van Tintelen Journal: Eur J Hum Genet Date: 2013-06-05 Impact factor: 4.246